Trial reportActa orthopaedica2026
Similar 2 year migration patterns for a shortened and a distally reduced stem design in uncemented total hip arthroplasty: a randomized controlled trial using radiostereometric analysis.
Trial report in Acta orthopaedica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03409666 (Randomized Controlled Study Comparing the Taperloc Complete Versus the Taperloc Complete Microplasty.), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Randomized Controlled Study Comparing the Taperloc Complete Versus the Taperloc Complete Microplasty.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
background and purposeThe primary objective was to compare subsidence and retroversion in the first 2 postoperative years of 2 uncemented hip stem designs in primary minimally invasive anterior-supine surgical (MIS-ASI) total hip arthroplasty: a shortened hip stem (Microplasty) and a standard-length stem with reduced distal width (Reduced Distal). Secondary objectives were to compare migration patterns, patient-reported outcome measures (PROMs), clinical and radiological scores, and the occurrence of (serious) adverse events up to 2 years postoperatively.
methods50 patients were randomized in this non-blinded, single-surgeon, industry-funded, radiostereometric analysis study (RSA) (ClinicalTrials.gov NCT03409666). Stem migration was measured relative to directly postoperative at 6 weeks, 1 year, and 2 years postoperatively, using model-based RSA. Linear mixed-effect modelling was used to compare migration. Primary outcomes were subsidence and retroversion at 2 years postoperatively. Secondary outcomes were migration, PROM questionnaires, clinical and radiological scores, and the presence of adverse events in the first 2 postoperative years.
resultsMigration of 15 Microplasty and 20 Reduced Distal stems showed comparable initial migration between direct and 6 weeks postoperative RSA, stabilizing thereafter. Predominant migration directions were subsidence and retroversion with mean values at 2 years of 1.47 mm (95% confidence interval [CI] 0.32-2.61) and 2.57° (CI 1.64-3.50) for the Microplasty stem and 2.35 mm (CI 1.36-3.34) and 1.59° (CI 0.79-2.39) for the Reduced Distal stem. At 6 weeks postoperatively, posterior tilt about the medial-lateral axis was different between stem designs, with 0.07° (CI -0.27 to 0.40) for the Microplasty and 0.48° (CI 0.19-0.77) for the Reduced Distal designs. Secondary outcomes were not clinically different between the stem designs.
conclusionWe showed that initial subsidence and retroversion for both stem designs in MIS-ASI surgery was present, although likely not clinically relevant. There was no statistically significant difference in subsidence and retroversion between the stem designs. Although initial migration varied substantially between patients and the Reduced Distal design showed more posterior tilting, both designs maintained a stable position from 6 weeks to 2 years postoperatively.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.